Findings of this study suggest that genotyping for the PNPLA3 I148M variant may be useful in refining the risk stratification of persons with obesity and excessive drinking who are at risk for advanced liver disease progression and may be candidates for early preventive measures. This evidence concerns the gene PNPLA3 and obesity due to melanocortin 4 receptor deficiency.